Literature DB >> 26646424

Implementation of World Health Organization Package of Essential Noncommunicable Disease Interventions (WHO PEN) for Primary Health Care in Low-Resource Settings: A Policy Statement From the World Hypertension League.

Xin H Zhang1, Liu Lisheng2, Norm R C Campbell3, Mark L Niebylski4, Peter Nilsson5, Daniel T Lackland6.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26646424      PMCID： PMC8031603          DOI： 10.1111/jch.12749

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN： 1524-6175            Impact factor:   3.738


× No keyword cloud information.
  47 in total

1.  Controlling Hypertension to Prevent Target Organ Damage: Perspectives from the World Hypertension League President.

Authors:  Daniel T Lackland
Journal:  Ethn Dis       Date:  2016-07-21       Impact factor: 1.847

2.  Use of Healthcare Services by Patients with Non-Communicable Diseases in Nepal: A Qualitative Study with Healthcare Providers.

Authors:  Saval Khanal; Lennert Veerman; Lisa Nissen; Samantha Hollingworth
Journal:  J Clin Diagn Res       Date:  2017-06-01

Review 3.  Improving clinical practice in primary care for the prevention and control of noncommunicable diseases: a multi-actor approach to two regional pilot projects in Kazakhstan.

Authors:  Erica Barbazza; Saltanat Yegeubayeva; Baktygul Akkazieva; Elena Tsoyi; Evgeny Zheleznyakov; Juan E Tello
Journal:  Cardiovasc Diagn Ther       Date:  2019-04

4.  Delivery and impact of the NHS Health Check in the first 8 years: a systematic review.

Authors:  Adam Martin; Catherine L Saunders; Emma Harte; Simon J Griffin; Calum MacLure; Jonathan Mant; Catherine Meads; Fiona M Walter; Juliet A Usher-Smith
Journal:  Br J Gen Pract       Date:  2018-06-18       Impact factor: 5.386

5.  Volunteerism, and alignment, are needed for a major paradigm shift in approaches to hypertension control: 2016 World Hypertension League Excellence Award in Hypertension Prevention and Control and the Distinguished Service Award.

Authors:  Norm R C Campbell
Journal:  J Clin Hypertens (Greenwich)       Date:  2017-04-20       Impact factor: 3.738

6.  Reducing premature mortality from non-communicable diseases, including for people with severe mental disorders.

Authors:  Cherian Varghese
Journal:  World Psychiatry       Date:  2017-02       Impact factor: 49.548

7.  Controlling hypertension and reducing its associated morbidity and mortality in the Caribbean: implications of race and ethnicity.

Authors:  Paige Colgrove; Kenneth L Connell; Daniel T Lackland; Pedro Ordunez; Donald J DiPette
Journal:  J Clin Hypertens (Greenwich)       Date:  2017-07-28       Impact factor: 3.738

Review 8.  Cardiovascular disease in the Eastern Mediterranean region: epidemiology and risk factor burden.

Authors:  Karam Turk-Adawi; Nizal Sarrafzadegan; Ibtihal Fadhil; Kathryn Taubert; Masoumeh Sadeghi; Nanette K Wenger; Nigel S Tan; Sherry L Grace
Journal:  Nat Rev Cardiol       Date:  2017-09-21       Impact factor: 32.419

9.  High Blood Pressure 2016: Why Prevention and Control Are Urgent and Important. The World Hypertension League, International Society of Hypertension, World Stroke Organization, International Diabetes Foundation, International Council of Cardiovascular Prevention and Rehabilitation, International Society of Nephrology.

Authors:  Norm R Campbell; Tej Khalsa; Daniel T Lackland; Mark L Niebylski; Peter M Nilsson; Kimbree A Redburn; Marcelo Orias; Xin-Hua Zhang; Louise Burrell; Masatsugu Horiuchi; Neil R Poulter; Dorairaj Prabhakaran; Agustin J Ramirez; Ernesto L Schiffrin; Rhian M Touyz; Ji-Guang Wang; Michael A Weber
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-06-17       Impact factor: 3.738

10.  Alternative Strategies to Achieve Cardiovascular Mortality Goals in China and India: A Microsimulation of Target- Versus Risk-Based Blood Pressure Treatment.

Authors:  Sanjay Basu; John S Yudkin; Jeremy B Sussman; Christopher Millett; Rodney A Hayward
Journal:  Circulation       Date:  2016-01-13       Impact factor: 29.690
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.